Latest filing published 05 Feb 2024 for 엔케이젠바이오텍코리아.
유형석: trading record in brief
유형석 discloses dealings in 엔케이젠바이오텍코리아 to DART (FSS). The record holds 2 filings, for trades running from 10 January 2024 to 26 January 2024.
In open-market terms, that means 1 purchase on one side and 1 sale worth €127k on the other. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 5 February 2024 came the latest disclosure, an open-market purchase in 엔케이젠바이오텍코리아. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 유형석
Open company profiles for insider transactions, fundamentals and analyst consensus when available.